Bivalirudin versus heparin as an antithrombotic agent in patients treated with a sirolimus-eluting stent

American Journal of Cardiology

Volumn 94, Issue 8, 2004, Pages 1047-1050

  Rha, Seung Woon ^a   Kuchulakanti, Pramod K ^a   Pakala, Rajbabu ^a   Cheneau, Edouard ^a   Fournadjiev, Jana A ^a   Pinnow, Ellen ^a   GebreEyesus, Afework ^a   Aggrey, George ^a   Wang, Zuyue ^a   Pichard, Augusto D ^a   Satler, Lowell F ^a   Kent, Kenneth M ^a   Lindsay, Joseph ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; HEPARIN; HIRULOG; RAPAMYCIN; TICLOPIDINE; WARFARIN;

ADULT; AGED; ARTERIOVENOUS FISTULA; ARTICLE; BLEEDING; BLOOD VESSEL INJURY; BRAIN HEMORRHAGE; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FALSE ANEURYSM; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMATOMA; HUMAN; ISCHEMIA; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVASCULARIZATION;

ANTICOAGULANTS; DRUG CARRIERS; FEMALE; HEPARIN; HIRUDINS; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SIROLIMUS; STENTS; THROMBOSIS;

EID: 5044227780     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.06.065     Document Type: Article

References (5)

1. J.A. Bittl, J. Strony, J.A. Brinker, W.H. Ahmed, C.R. Meckel, B.R. Chaitman, J. Maraganore, E. Deutsch, B. Adelman Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina N Engl J Med 333 1995 764 769
2. J.A. Bittl, B.R. Chaitman, F. Feit, W. Kimball, E.J. Topol Bivalirudin Angioplasty Study Investigators Bivalirudin vs heparin during coronary angioplasty for unstable or post-infarction angina; final report reanalysis of the Bivalirudin Angioplasty Study Am Heart J 142 2001 952 959
3. R. Wolfram, L. Leborgne, E. Cheneau, E.E. Pinnow, D.A. Canos, D. Hellinga, L.F. Satler, A.D. Pichard, K.M. Kent, R. Waksman Comparison of effectiveness and safety of three different antothrombotic regimens (bivalirudin, eptifibatide, and heparin) in preventing myocardial ischemia during percutaneous coronary intervention Am J Cardiol 92 2003 1080 1083
4. A.M. Lincoff, J.A. Bittl, R.A. Harrington, F. Feit, N.S. Kleiman, J.D. Jackson, I.J. Sarembock, D.J. Cohen, D. Spriggs, R Ebrahimi REPLACE-2 Investigators Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 Randomized Trial JAMA 289 2003 853 863
5. A.K. Rao, C. Pratt, A. Berke, I. Ockene, T.L. Schreiber, W.R. Bell, G. Knatterud, T.L. Robertson, M.L. Terrin Thrombolysis In Myocardial Infarction (TIMI) Trial, phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase J Am Coll Cardiol 11 1988 1 11